The most preferred liquid composition to be filled into a container of the device according to the present invention is a suspension comprising a fibrinogen component, a thrombin component, and optional additives such as aprotinin (which acts as protease inhibitor), calcium ions or heparin antagonists in alcohol such as ethanol, n- or i-propanol or other organic solvents.